Asynchronous ADHD Assessment: New Tools for Better Evaluation
Author(s)Leah Kuntz, Barry K. Herman, MD, MMM
Key Takeaways
- Timely ADHD assessments prevent worsening functional impairment and reduce healthcare costs, with untreated ADHD’s economic burden exceeding $120 billion annually in the US.
- The Mentavi Diagnostic Evaluation offers a validated, asynchronous online assessment, providing reliable diagnoses quickly and affordably compared to traditional methods.
- Adult ADHD diagnosis is complex due to overlapping symptoms with mood disorders; Mentavi’s structured, self-paced assessment improves diagnostic accuracy and access.
- The evaluation enhances patient understanding and engagement, promoting shared decision-making and adherence to treatment plans, crucial for effective ADHD management.
- Clinicians benefit from the tool’s accuracy, reducing inappropriate prescribing and aligning treatment with best practices, crucial amid a national shortage of mental health professionals.
Discover how Mentavi Health’s innovative ADHD assessment enhances diagnosis speed, accuracy, and patient engagement in mental health care.
Telepsychiatry practice Quintessence Psychiatry recently adopted a clinically validated diagnostic tool to change the patient care workflow: Mentavi Health’s clinically validated asynchronous Diagnostic Evaluation for adult attention-deficit/hyperactivity disorder (ADHD) assessments, an alternative to a structured clinical interview. These assessments are reviewed by a clinician and returned in approximately 5 days, frequently after patients complete the evaluation at home in 60 to 90 minutes. Psychiatric Times sat down with Barry K. Herman, MD, MMM, Mentavi Health’s chief medical officer, to learn more about the Mentavi Diagnostic Evaluation and ADHD assessment as a whole.
Read the complete article: Asynchronous ADHD Assessment: New Tools for Better Evaluation